Designing cancer prevention trials: a stochastic model approach.

Area of Science:

• Oncology
• Biostatistics
• Epidemiology

Background:

• Growing interest in cancer prevention trials necessitates improved planning methodologies.
• Interventions aim to disrupt carcinogenesis or preclinical disease stages.
• Existing models may not fully capture complexities of trial design and intervention effects.

Purpose of the Study:

• To develop and present multi-stage stochastic models for planning cancer prevention trials.
• To provide a framework for balancing key trial design parameters like sample size and follow-up duration.
• To incorporate intervention mechanisms and patient compliance into trial planning.

Main Methods:

• Development of multi-stage stochastic models tailored for cancer prevention.
• Calculation of disease incidence for control and intervention groups based on model inputs.
• Optimization of trial designs to balance sample size, follow-up time, and statistical error probabilities.

Main Results:

• The models enable calculation of disease incidence, aiding in informed trial design.
• Designs can be optimized to balance sample size and follow-up time while controlling error rates.
• Application to breast cancer illustrates the model's utility in planning intervention trials.

Conclusions:

• Multi-stage stochastic models offer a robust approach to planning cancer prevention trials.
• The models provide a quantitative method to balance critical trial design elements.
• The framework is adaptable for planning trials for various chronic diseases beyond cancer.